|1.||Seery, Gerald B: 1 article (01/2003)|
|2.||Gilbert, Carl W: 1 article (01/2003)|
|3.||McGowan, Eleanor B: 1 article (01/2003)|
|4.||Pegram, Mark D: 1 article (01/2003)|
|5.||Black, Kirby S: 1 article (01/2003)|
01/01/2003 - "This suggests that targeted delivery of paclitaxel using A-Z-CINN 310 kills tumor cells by localized release of paclitaxel at the tumor site, which can be accelerated by light treatment. "
01/01/2003 - "After treatment with A-Z-CINN 310, some mice received light exposure at 6 h for 5 min adjacent to the tumor to cause light-accelerated release of paclitaxel. "
01/01/2003 - "This study demonstrates the effectiveness of a single-treatment use of A-Z-CINN 310 in decreasing tumor volume and tumor cell density of human HER-2-positive BT-474 mammary tumor cells implanted in scid mice, compared to treatment with simultaneously administered trastuzumab and paclitaxel and with saline control. "
01/01/2003 - "Animals treated with A-Z-CINN 310, then light, showed dose-dependent decreases in tumor volume and tumor cell density which were more rapid and extensive than those seen with A-Z-CINN 310 without light or a 10-fold higher concentration of co-administered trastuzumab plus paclitaxel. "